Cost-effectiveness of ustekinumab in moderate to severe Crohn’s disease in Sweden

por Hansson-Hedblom, Amanda, Almond, Chrissy, Borgström, Fredrik, Sly, Indeg, Enkusson, Dana, Troelsgaard Buchholt, Anders, Karlsson, Linda
Publicado 2018

The Cost-Effectiveness of Lorlatinib Versus Chemotherapy as a Second- or Third-Line Treatment in Anaplastic Lymphoma Kinase (ALK)-Positive Non-small-cell Lung Cancer in Sweden

por Nilsson, Fredrik O. L., Asanin, Sandra T., Masters, Elizabeth T., Iadeluca, Laura, Almond, Chrissy, Cooper, Miranda, Smith, Sarah
Publicado 2021